Intrauterine Device Clinical Trial
Official title:
The Effect of Virtual Reality on Anxiety During Intrauterine Device Insertion: Randomised Controlled Experimental Study
This study was planned to determine whether the use of virtual reality glasses during intrauterine device insertion has an effect on the anxiety level of women.
Status | Recruiting |
Enrollment | 80 |
Est. completion date | February 28, 2026 |
Est. primary completion date | February 28, 2026 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 85 Years |
Eligibility | Inclusion Criteria: - -Volunteering to participate in the research - Answering questionnaire and scale forms completely - Read and understand Turkish - 18 years of age or older - STAI score of 35 and above - Not being pregnant, - No complaints of acute pelvic pain, - No damage or leysone in the perineum that may cause pain during examination, - Not using a pharmacological agent or method with analgesic or anxiolytic effect 24 hours before the application, - No vaginismus problem, - Absence of a history of sexual abuse, - Not having any physical or mental problems that may prevent communication. Exclusion Criteria: - -Not volunteering to participate in the research, - Incomplete responses to questionnaires and scale forms - Not understanding Turkish, - Under 18 years of age - Do not score less than 35 points on the STAI, - Don't be pregnant, - Complaint of acute pelvic pain, - Any damage or leysone in the perineum that may cause pain during examination, - Having used a pharmacological agent or method with analgesic or anxiolytic effect 24 hours before the application, - Having a vaginismus problem, - Previous history of sexual abuse, - Having any physical or mental problem that prevents communication. |
Country | Name | City | State |
---|---|---|---|
Turkey | 1.Murat State Hospital | Edirne |
Lead Sponsor | Collaborator |
---|---|
Kirklareli University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Introductory Information Form | The form consists of questions about socio-demographic and intrauterine device insertion | between one to six months | |
Primary | The State/Trait Anxiety Inventory (STAI) | This inventory was developed by Spielberg in 1973 and each of the subscales ranges from 1 (not at all) to 4 (very much). The lowest and highest scores that can be obtained from each subscale are 20 and 80, respectively. Higher scores are associated with more anxiety. The alpha value of the scale varies between 0.86 and 0.92 . Öner et al. 1983, it was shown that the alpha value of the Turkish version of the STAI ranged between 0.83 and 0.87.27. | between one to six months | |
Primary | Visual Anolag Scale (VAS) | It was developed by Price et al. (1983) to assess the severity of pain (Price et al. 1983). It is a line, usually 10 cm long, horizontal or vertical, starting with "No Pain" and ending with "Intolerable Pain". This line may be just a straight line, or it may be divided into equal intervals, or it may have description words placed on the line to describe pain. It is generally accepted that the vertical line is easier to understand. The patient indicates the intensity of his/her pain with a mark on this line where he/she deems appropriate. The distance between the beginning of no pain and this point is measured in "cm" and recorded. Values vary between 0 and 10 and higher values indicate increased pain. Turkish validity and reliability was performed by Eti Aslan (Eti Aslan, 2004). | between one to six months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03686085 -
Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women.
|
Phase 3 | |
Recruiting |
NCT05550064 -
Structured Contraceptive Counseling During Pregnancy
|
N/A | |
Completed |
NCT03383432 -
Intrauterine Device Insertion: a Step for High Satisfaction
|
N/A | |
Completed |
NCT03600064 -
Misoprostol for Cervical Ripening Before Copper Intrauterine Device Removal
|
N/A | |
Completed |
NCT05556421 -
Can Uterocervical Angle Predict the Displacement of Copper Intrauterine Devices (T-Cu 380A)
|
||
Completed |
NCT04045548 -
Vaginal Dinoprostone Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System in Women With no Previous Vaginal Delivery
|
Phase 4 | |
Completed |
NCT03870711 -
10% Lidocaine Spray for Intrauterine Device Insertion
|
Phase 4 | |
Completed |
NCT02898831 -
Cold Compress for Pain Associated With Intrauterine Device Insertion
|
N/A |